Thus, we propose that SEC62 functions as a migration-stimulating oncogene in the carcinogenesis of cervical cancer and constitutes not only a potential marker for 3q26 amplification but also a potential target for anti-cancer treatment. The gene discussed is SEC62; the disease is cervical cancer.